About
Microbiome Correction
Areas of Focus
Categories
Biologics & BiopharmaceuticalMicrobiome
Team (22)
Clinical Trials (11)
View allTotal Trials
11
As Lead Sponsor
10
As Collaborator
1
Total Enrollment
805
By Phase
PHASE2: 4PHASE1: 2PHASE3: 1NA: 2PHASE1/PHASE2: 1
By Status
COMPLETED: 5RECRUITING: 2NOT_YET_RECRUITING: 1ACTIVE_NOT_RECRUITING: 1TERMINATED: 1AVAILABLE: 1
Clinical Trials Pipeline10 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
Today
Hover over trial bars to see details
Recent Trials
NCT07001618Collaborator
Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
PHASE2Not yet recruiting
162 participants
Started: Sep 30, 2025 · Completed: Sep 30, 2032
NCT05762211Lead Sponsor
Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications (PHOEBUS Trial)
PHASE2Recruiting
387 participants
Started: Oct 31, 2023 · Completed: Feb 15, 2027
NCT05889572Lead Sponsor
Safety and Gut Microbiota Analysis of an Oral Microbiotherapy in Patients With Amyotrophic Lateral Sclerosis
PHASE1Completed
15 participants
Started: Jun 8, 2023 · Completed: Jul 22, 2024
NCT04769895Lead Sponsor
MaaT013 As Salvage Therapy in Ruxolitinib Refractory GI-aGVHD Patients
PHASE3Active, not recruiting
66 participants
Started: Mar 25, 2022 · Completed: Nov 30, 2025
NCT05017688Lead Sponsor
Prospective Interventional Study Exploring the Microbiota Recolonization in SR-GvHD Patients Receiving MaaT013
NARecruiting
40 participants
Started: Oct 6, 2021 · Completed: Dec 31, 2024
Locations (1)
Headquarters
Lyon, France
Map
Loading map...